Published trade mark details for 2514997

This information was published on 2025-03-25T00:10:51 for IP Right Acceptance Published.

Field	Value
(210)	2514997
(220)	20 Jan 2025
(300)	US, 24 Oct 2024, 98817650
(511) (510)	Class 5 Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson’s disease, Alzheimer’s disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors
(540)
(550)	Figurative
(730)	DECIPHERA PHARMACEUTICALS, LLC
(750)	AJ Park

 

Find out more about publications on the About page.